Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice

This study has been terminated.
(Terminated due to problems enrolling adequate number of patients.)
Sponsor:
Information provided by (Responsible Party):
Ferring Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01748591
First received: November 9, 2012
Last updated: December 21, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)